Itay Itzhaky - Chairman of the BoardMr. Itay Itzhaky has over 25 years of managerial and entrepreneurial experience in the pharmaceutical and healthcare industries in Israel.
During 2007-2012, Mr. Itzhaky served as CEO of NiTi Surgical Solutions, leading the company in development of Nitinol-based disruptive medical devices. Prior to NiTi, Mr. Itzhaky was CEO of ColBar, a biomaterials company (acquired by Johnson & Johnson). Before Colbar, Itay spent 7 years at Teva Pharmaceutical Industries in senior operational positions, managing generic and innovative drug-development operations. Itay was VP Business Development at Promedico, the largest drug importer in Israel (representing Novartis, Pfizer, Abbott etc.). In this capacity, he founded and managed start-up subsidiaries in the medical device and pharmaceutical fields. Prior to these positions, Mr. Itzhaky served as CEO of Eldan Electronic instruments, representing medical device and life science companies such as Hewlett-Packard (Agilent), Amersham Pharmacia Biotech etc.
Mr. Itzhaky holds a B.Sc. in Industrial Engineering from Ben-Gurion University of the Negev, Beer-Sheba, Israel and an MBA from Bar Ilan University, Ramat Gan, Israel.
Arie Goldlust, Ph.D.Dr. Arie Goldlust has over 25 years of R&D experience in the medical device, biotechnology and pharmaceutical industries.
Prior to founding Datum Biotech, Dr. Goldlust served for 10 years at ColBar LifeScience, a J&J subsidiary, where he served at different capacities with gradual increase responsibilities. In his last capacity as VP Technology and R&D, Arie led the company's development of two worldwide commercialized collagen based products. He managed all R&D activities supporting the regulatory, clinical, manufacturing, quality and marketing development of those products.
He also developed a range of novel tissue engineering scaffolds and led collaborations with different J&J research units in a variety of other biomaterial projects.
Prior to joining Colbar, Arie was Manager of Process Development and Protein Research at CBD Technologies, Ltd and before that, he held a research position at the Department of Process Development of Biotechnology General.
Dr. Goldlust received his Ph.D and M.Sc. degrees in biochemistry from the Weizmann Institute of Science, Rehovot, Israel and his B.Sc. degree from the Hebrew University of Jerusalem.. He completed his post‐doctoral training at the Department of Biological‐Chemistry, University of Michigan Medical School, Ann Arbor, Michigan USA and at the Department of Biotechnology, Parke‐Davis Pharmaceutical‐Research Division of Warner‐Lambert Company, Ann Arbor, Michigan USA.
Yuval Zubery D.M.D.Dr. Yuval Zubery has over 25 years of experience in dentistry and periodontics. Since 1995, Dr. Zubery has had his own private practice specializing in periodontics and dental implants.
Author of over 30 publications, he has been invited to speak on periodontics, regeneration and dental implantology at international events.
Dr. Zubery received his D.M.D. degree in 1984 and his specialty certificate in Periodontics in 1988 from the Dental School of the Hebrew University in Jerusalem. Yuval was lecturer in the Section of Periodontics, School of Dental Medicine, Tel-Aviv University, Israel from 1988 until 1995. He was visiting Assistant Professor in the Department of Periodontics, University of Texas, Health Science Center in San Antonio, Texas U.S.A. in 1991-1992.
Yuval Eylat D.M.D.With over 29 years of experience in dentistry, Dr. Eylat is Co-founder and Instructor at the Ronald E Goldstein Center for Esthetic Dentistry and Dental Materials Research, Department of Prosthodontics, Hebrew University-Hadassah School of Dental Medicine, Jerusalem, Israel. Dr. Eylat is also an Instructor at the School of Dental Medicine, at The Hebrew University in Jerusalem.
He lectures internationally on dental esthetics and on a new endodontic file system. Yuval is also co-author of several publications.
Dr. Eylat graduated in 1984 from the School of Dental Medicine, The Hebrew University in Jerusalem, Israel.